Wen, Shilai, Jingke Zeng, Liting Zhong, Jianmin Ye, and Xiaohuan Lai. 2022. “The Efficacy and Adverse Effects of Nivolumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma: Nivolumab and Lenvatinib in the Treatment of HCC”. Cellular and Molecular Biology 68 (11):53-57. https://doi.org/10.14715/cmb/2022.68.11.10.